Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
Completed · Phase 2 · Has a placebo group
Conditions studied: Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive, Lung Diseases, Respiratory Hypersensitivity, Hypersensitivity, Immediate, Hypersensitivity, Immune System Diseases
In brief
A phase 2, multicentre, randomized, double-blind, placebo-controlled, parallel group study to evaluate the effect of tezepelumab on airway inflammation in adults with inadequately controlled asthma.
Key facts
- Study ID
- NCT03688074
- Run by
- AstraZeneca
- People needed
- 116
- Starts
- 2018-11-02
- Expected to finish
- 2020-11-16
- Last updated by the study team
- 2022-02-21
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Denver, Colorado, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Galveston, Texas, United States
- Research Site — Calgary, Alberta, Canada
- Research Site — Vancouver, British Columbia, Canada
- Research Site — Hamilton, Ontario, Canada
- Research Site — Ottawa, Ontario, Canada
- Research Site — Montreal, Quebec, Canada
- Research Site — Québec, Quebec, Canada
- Research Site — Aalborg, Denmark
- Research Site — Aarhus N, Denmark
- Research Site — Hvidovre, Denmark
- Research Site — København NV, Denmark
- Research Site — Næstved, Denmark
- Research Site — Odense C, Denmark
- Research Site — Vejle, Denmark
- Research Site — Frankfurt, Germany
- Research Site — Frankfurt am Main, Germany
- Research Site — Großhansdorf, Germany
- Research Site — Landsberg, Germany
- Research Site — Cambridge, United Kingdom
- Research Site — Headington, United Kingdom
- Research Site — Leicester, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.